{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T13:33:11Z","timestamp":1785418391134,"version":"3.56.0"},"reference-count":22,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T00:00:00Z","timestamp":1633392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,31]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Paradoxical reactions in central nervous system tuberculosis (CNS-TB) are associated with significant morbidity and mortality. We describe 4 HIV-uninfected children treated for CNS-TB with severe paradoxical reactions unresponsive to corticosteroids. All made recovery after treatment with infliximab, highlighting the safety and effectiveness of infliximab for this complication, and need for prospective trials.<\/jats:p>","DOI":"10.1093\/jpids\/piab094","type":"journal-article","created":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T19:55:56Z","timestamp":1632858956000},"page":"1087-1091","source":"Crossref","is-referenced-by-count":18,"title":["Infliximab for Paradoxical Reactions in Pediatric Central Nervous System Tuberculosis"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-6395","authenticated-orcid":false,"given":"Yara-Natalie","family":"Abo","sequence":"first","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Curtis","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Osowicki","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle","family":"Haeusler","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Purcell","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seilesh","family":"Kadambari","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"De Wachter","sequence":"additional","affiliation":[{"name":"Division of Paediatric Neurology, Department of Paediatrics, Antwerp University Hospital, University of Antwerp, Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Vanden Driessche","sequence":"additional","affiliation":[{"name":"Division of Paediatric Pulmonology, Department of Paediatrics, University Hospital Antwerp, Edegem, Belgium"},{"name":"Section of Paediatric Infectious Diseases, Laboratory of Medical Immunology, Radboud Centre for Infectious Diseases, Radboud University Medical Centre, Nijmegen, The Netherlands"},{"name":"DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research and SA\/MRC Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Dekeyzer","sequence":"additional","affiliation":[{"name":"Department of Radiology, Antwerp University Hospital (UZA), Edegem, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Coleman","sequence":"additional","affiliation":[{"name":"Department of Radiology, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel","family":"Crawford","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, Royal Children\u2019s Hospital, Melbourne, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Graham","sequence":"additional","affiliation":[{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Marais","sequence":"additional","affiliation":[{"name":"The Children\u2019s Hospital at Westmead, Westmead, New South Wales, Australia"},{"name":"Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Gwee","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, The Royal Children\u2019s Hospital Melbourne, Parkville, Victoria, Australia"},{"name":"Department of Paediatrics, The University of Melbourne, Parkville, Victoria, Australia"},{"name":"Murdoch Children\u2019s Research Institute, Parkville, Victoria, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,10,5]]},"reference":[{"key":"2021123116213202000_CIT0001","doi-asserted-by":"crossref","first-page":"167","DOI":"10.12688\/wellcomeopenres.15535.1","article-title":"The current global situation for tuberculous meningitis: epidemiology, diagnostics, treatment and outcomes [version 1; peer review: 2 approved]","volume":"4","author":"Seddon","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2021123116213202000_CIT0002","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1473-3099(14)70852-7","article-title":"Treatment outcomes of childhood tuberculous meningitis: a systematic review and meta-analysis","volume":"14","author":"Chiang","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"2021123116213202000_CIT0003","doi-asserted-by":"crossref","first-page":"31","DOI":"10.12688\/wellcomeopenres.14006.2","article-title":"Adjunctive dexamethasone for the treatment of HIV-infected adults with tuberculous meningitis (ACT HIV): study protocol for a randomised controlled trial","volume":"3","author":"Donovan","year":"2018","journal-title":"Wellcome Open Res"},{"key":"2021123116213202000_CIT0004","year":"2017"},{"key":"2021123116213202000_CIT0005","year":"2020"},{"key":"2021123116213202000_CIT0006","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/QCO.0000000000000331","article-title":"Recent advances in the diagnosis and management of tuberculous meningitis","volume":"30","author":"Mai","year":"2017","journal-title":"Curr Opin Infect Dis"},{"key":"2021123116213202000_CIT0007","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/cid\/ciu641","article-title":"Neutrophil-associated central nervous system inflammation in tuberculous meningitis immune reconstitution inflammatory syndrome","volume":"59","author":"Marais","year":"2014","journal-title":"Clin Infect Dis"},{"key":"2021123116213202000_CIT0008","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1086\/515327","article-title":"A combination of thalidomide plus antibiotics protects rabbits from mycobacterial meningitis-associated death","volume":"177","author":"Tsenova","year":"1998","journal-title":"J Infect Dis"},{"key":"2021123116213202000_CIT0009","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/clinids\/21.4.924","article-title":"Concentrations of interferon gamma, tumor necrosis factor alpha, and interleukin-1 beta in the cerebrospinal fluid of children treated for tuberculous meningitis","volume":"21","author":"Donald","year":"1995","journal-title":"Clin Infect Dis"},{"key":"2021123116213202000_CIT0010","doi-asserted-by":"crossref","first-page":"e22626","DOI":"10.1097\/MD.0000000000022626","article-title":"Tumor necrosis factor antagonists for paradoxical inflammatory reactions in the central nervous system tuberculosis: case report and review","volume":"99","author":"Santin","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2021123116213202000_CIT0011","doi-asserted-by":"crossref","first-page":"ofaa604","DOI":"10.1093\/ofid\/ofaa604","article-title":"Use of infliximab to treat paradoxical tuberculous meningitis reactions","volume":"8","author":"Marais","year":"2021","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"2021123116213202000_CIT0012","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1097\/INF.0000000000002578","article-title":"Successful treatment of a severe vision-threatening paradoxical tuberculous reaction with infliximab: first pediatric use","volume":"39","author":"Abo","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"2021123116213202000_CIT0013","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1086\/598988","article-title":"Neurologic manifestations of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome: a case series","volume":"48","author":"Pepper","year":"2009","journal-title":"Clin Infect Dis"},{"key":"2021123116213202000_CIT0014","doi-asserted-by":"crossref","first-page":"156","DOI":"10.5694\/mja14.00716","article-title":"Infliximab therapy in two cases of severe neurotuberculosis paradoxical reaction","volume":"202","author":"Molton","year":"2015","journal-title":"Med J Aust"},{"key":"2021123116213202000_CIT0015","doi-asserted-by":"crossref","first-page":"158","DOI":"10.12688\/wellcomeopenres.15501.2","article-title":"Management of intracranial tuberculous mass lesions: how long should we treat for?","volume":"4","author":"Marais","year":"2019","journal-title":"Wellcome Open Res"},{"key":"2021123116213202000_CIT0016","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jns.2009.12.012","article-title":"Vision impairment in tuberculous meningitis: predictors and prognosis","volume":"290","author":"Sinha","year":"2010","journal-title":"J Neurol Sci"},{"key":"2021123116213202000_CIT0017","doi-asserted-by":"crossref","first-page":"1179573517722512","DOI":"10.1177\/1179573517722512","article-title":"Inhibition of inflammation mediated through the tumor necrosis factor \u03b1 biochemical pathway can lead to favorable outcomes in Alzheimer disease","volume":"9","author":"Shamim","year":"2017","journal-title":"J Cent Nerv Syst Dis"},{"issue":"6","key":"2021123116213202000_CIT0018","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1007\/s12035-021-02293-1","article-title":"Infliximab can improve traumatic brain injury by suppressing the tumor necrosis factor alpha pathway","volume":"58","author":"Zhou","year":"2021","journal-title":"Mol Neurobiol"},{"key":"2021123116213202000_CIT0019","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fonc.2018.00239","article-title":"Beyond the blood:brain barrier: the importance of central nervous system (CNS) pharmacokinetics for the treatment of CNS tumors, including diffuse intrinsic pontine Glioma","volume":"8","author":"Warren","year":"2018","journal-title":"Front Oncol"},{"key":"2021123116213202000_CIT0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MPG.0000000000002631","article-title":"Pharmacokinetics, pharmacodynamics, and immunogenicity of Infliximab in pediatric inflammatory bowel disease: a systematic review and revised dosing considerations","volume":"70","author":"Winter","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021123116213202000_CIT0021","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/MPG.0000000000003044","article-title":"Safety of biological therapy in children with inflammatory bowel disease","volume":"72","author":"D\u2032Arcangelo","year":"2021","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021123116213202000_CIT0022","year":"2020"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/10\/12\/1087\/41999099\/piab094.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpids\/article-pdf\/10\/12\/1087\/41999099\/piab094.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,31]],"date-time":"2021-12-31T16:23:05Z","timestamp":1640967785000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/10\/12\/1087\/6381472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,5]]},"references-count":22,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2021,10,5]]},"published-print":{"date-parts":[[2021,12,31]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piab094","relation":{},"ISSN":["2048-7207"],"issn-type":[{"value":"2048-7207","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,10,5]]}}}